{"id":431,"date":"2007-05-25T14:44:39","date_gmt":"2007-05-25T18:44:39","guid":{"rendered":"http:\/\/piel-l.org\/blog\/?p=431"},"modified":"2007-07-06T08:20:01","modified_gmt":"2007-07-06T12:20:01","slug":"photodynamic-therapy-with-topical-methyl-aminolaevulinate-for-difficult-to-treat-basal-cell-carcinoma","status":"publish","type":"post","link":"https:\/\/piel-l.org\/blog\/431","title":{"rendered":"Photodynamic therapy with topical methyl aminolaevulinate for \u2018difficult-to-treat\u2019 basal cell carcinoma"},"content":{"rendered":"<p><strong>Background<\/strong> Basal cell carcinoma (BCC) may be difficult to treat by conventional means, particularly if the lesions are large or located in the mid-face (H-zone). Photodynamic therapy (PDT) using topical methyl aminolaevulinate (MAL) may be a good noninvasive option for these patients.<\/p>\n<p><strong>Objectives<\/strong> To investigate the efficacy and safety of PDT using MAL for BCCs defined as &lsquo;difficult to treat&#39;, i.e. large lesions, in the H-zone, or in patients at high risk of surgical complications.<\/p>\n<table cellspacing=\"0\" cellpadding=\"0\">\n<tr>\n<td><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/mail.google.com\/mail\/images\/pdf.gif\" width=\"16\" height=\"16\" \/><\/td>\n<td width=\"7\">&nbsp;<\/td>\n<td><strong>PDT with MAL for difficult to treat BCC.pdf<\/strong><br \/> 307K    <a href=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/2007\/05\/156\/PDT%20with%20MAL%20for%20difficult%20to%20treat%20BCC.pdf\" target=\"_blank\">Descargar documento<\/a> <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Background Basal cell carcinoma (BCC) may be difficult to treat by conventional means, particularly if the lesions are large or located in the mid-face (H-zone). Photodynamic therapy (PDT) using topical methyl aminolaevulinate (MAL) may be a good noninvasive option for these patients. Objectives To investigate the efficacy and safety of PDT using MAL for BCCs &hellip;<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[],"class_list":["post-431","post","type-post","status-publish","format-standard","","category-notigalderma"],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/431","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=431"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/431\/revisions"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=431"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/categories?post=431"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/tags?post=431"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}